Literature DB >> 33965613

Comparison of intravascular ultrasound and multidimensional contrast imaging modalities for characterization of chronic occlusive iliofemoral venous disease: A systematic review.

Taimur Saleem1, Seshadri Raju2.   

Abstract

BACKGROUND: Techniques to diagnose and treat chronic iliofemoral venous obstruction (CIVO) have continued to evolve. Intravascular ultrasound (IVUS) displays real-time cross-sectional venous anatomy and can be used to guide venous interventions. However, being invasive, it is not a suitable initial screening tool. The comparison of IVUS with other three-dimensional contrast imaging modalities is less well documented. We have provided a systematic analysis of the performance of IVUS and other three-dimensional contrast imaging modalities for the evaluation of CIVO.
METHODS: A search of various databases, including MEDLINE, Embase, EBSCOhost, Cochrane Library, CINAHL PLUS, and Web of Science, was conducted to identify studies that had compared IVUS and at least one other multidimensional contrast imaging modality, including multiplanar venography, computed tomography venography (CTV), computed tomography angiography, or magnetic resonance venography in the evaluation of CIVO.
RESULTS: A total of 2117 articles were screened. Of these, eight met the inclusion criteria. Additionally, 12 other studies were identified that had compared IVUS and single plane venography. A meaningful meta-analysis could not be conducted owing to data heterogeneity. The quality of evidence varied from very low to low. IVUS identified stenotic lesions in 0% to 30% more patients compared with multiplanar venography. The CTV and IVUS measurements correlated well with each other. The sensitivity of the two-segment CTV technique approached 97%. The specificity of CTV was 57% to 86% and varied with the venous segment. The sensitivity and specificity of magnetic resonance venography compared with IVUS was 100% and 22.7%, respectively.
CONCLUSIONS: Given that IVUS is considered the reference standard used to guide venous interventions in patients with CIVO, the use of venography, despite using multiple projection views, underestimates the severity and presence of venous stenosis and should not be used as the only diagnostic modality. Three-dimensional CTV is noninvasive with a high sensitivity. It can be used to screen patients who might benefit from a more invasive investigation with IVUS. CTV can also be considered for the preoperative planning of venous interventions in patients with CIVO.
Copyright © 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic venous occlusive disease; Computed tomography venography; IVUS; Iliac vein stent; Intravascular ultrasound; Magnetic resonance venography; Multiplanar venography

Mesh:

Substances:

Year:  2021        PMID: 33965613     DOI: 10.1016/j.jvsv.2021.03.022

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  4 in total

1.  In-stent restenosis and stent compression in iliofemoral venous stents.

Authors:  Taimur Saleem
Journal:  Quant Imaging Med Surg       Date:  2022-02

2.  The Application of MEVEC 3D Doppler Ultrasound Technique for a New Classification of Morpho-Functional Phenotypes in Lower Limbs Venous Diseases.

Authors:  Aldo Innocente Galeandro; Cristina Galeandro; Pietro Scicchitano; Rosanna Clima; Ilenia Annunziata Ritacco; Massimiliano Dellisanti Fabiano Vilardi; Egidio Di Ponzio; Annamaria Annichiarico; Francesco Ciciarello; Vincenzo Contursi; Angelika Elzbieta Wegierska; Marco Matteo Ciccone
Journal:  Vasc Health Risk Manag       Date:  2022-02-26

3.  Percutaneous laser recanalization in chronically occluded iliofemoral venous stents.

Authors:  Taimur Saleem; Cooper Luke; Seshadri Raju
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-07-06

4.  Utility of a percutaneous mechanical thrombectomy device in retrieval of an iatrogenic intravascular foreign body.

Authors:  Taimur Saleem
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.